These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 9170006)
21. Effects of sesamin on aortic oxidative stress and endothelial dysfunction in deoxycorticosterone acetate-salt hypertensive rats. Nakano D; Itoh C; Ishii F; Kawanishi H; Takaoka M; Kiso Y; Tsuruoka N; Tanaka T; Matsumura Y Biol Pharm Bull; 2003 Dec; 26(12):1701-5. PubMed ID: 14646174 [TBL] [Abstract][Full Text] [Related]
22. Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone/salt-treated mice. Chan CT; Moore JP; Budzyn K; Guida E; Diep H; Vinh A; Jones ES; Widdop RE; Armitage JA; Sakkal S; Ricardo SD; Sobey CG; Drummond GR Hypertension; 2012 Nov; 60(5):1207-12. PubMed ID: 23033370 [TBL] [Abstract][Full Text] [Related]
23. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension. Wang H; McNeill JR Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814 [TBL] [Abstract][Full Text] [Related]
24. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension. Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800 [TBL] [Abstract][Full Text] [Related]
26. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats. Itoh H; Nakao K; Mukoyama M; Yamada T; Hosoda K; Shirakami G; Morii N; Sugawara A; Saito Y; Shiono S J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622 [TBL] [Abstract][Full Text] [Related]
27. In vivo and in vitro magnesium effects on aortic prostacyclin generation in DOCA-salt hypertensive rats. Laurant P; Moussard C; Alber D; Henry JC; Berthelot A Prostaglandins Leukot Essent Fatty Acids; 1992 Nov; 47(3):183-6. PubMed ID: 1475272 [TBL] [Abstract][Full Text] [Related]
28. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Beswick RA; Dorrance AM; Leite R; Webb RC Hypertension; 2001 Nov; 38(5):1107-11. PubMed ID: 11711506 [TBL] [Abstract][Full Text] [Related]
29. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats. Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722 [TBL] [Abstract][Full Text] [Related]
30. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats. Kuro T; Okahara A; Nose M; Ikuse T; Matsumura Y Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359 [TBL] [Abstract][Full Text] [Related]
32. Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation. Prahalathan P; Kumar S; Raja B Metabolism; 2012 Aug; 61(8):1087-99. PubMed ID: 22386933 [TBL] [Abstract][Full Text] [Related]
33. The flavonoid morin restores blood pressure and lipid metabolism in DOCA-salt hypertensive rats. Prahalathan P; Saravanakumar M; Raja B Redox Rep; 2012; 17(4):167-75. PubMed ID: 22781105 [TBL] [Abstract][Full Text] [Related]
34. Role of the adrenal medullae in male and female DOCA-salt hypertensive rats. Lange DL; Haywood JR; Hinojosa-Laborde C Hypertension; 1998 Jan; 31(1 Pt 2):403-8. PubMed ID: 9453336 [TBL] [Abstract][Full Text] [Related]
35. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats. Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341 [TBL] [Abstract][Full Text] [Related]
36. Chronic blockade of neuronal nitric oxide synthase does not affect long-term control of blood pressure in normal, saline-drinking or deoxycorticosterone-treated rats. Wangensteen R; Sainz J; RodrÃguez-Gomez I; Moreno JM; Osuna A; Vargas F Exp Physiol; 2003 Mar; 88(2):243-50. PubMed ID: 12621529 [TBL] [Abstract][Full Text] [Related]
37. Endothelin enhances and inhibits adrenal catecholamine release in deoxycorticosterone acetate-salt hypertensive rats. Lange DL; Haywood JR; Hinojosa-Laborde C Hypertension; 2000 Jan; 35(1 Pt 2):385-90. PubMed ID: 10642329 [TBL] [Abstract][Full Text] [Related]
38. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats. Diaz J; Ni W; Thompson J; King A; Fink GD; Watts SW J Pharmacol Exp Ther; 2008 Jun; 325(3):1031-8. PubMed ID: 18305011 [TBL] [Abstract][Full Text] [Related]
39. Decreased vascular glucose transporter expression and glucose uptake in DOCA-salt hypertension. Atkins KB; Johns D; Watts S; Clinton Webb R; Brosius FC J Hypertens; 2001 Sep; 19(9):1581-7. PubMed ID: 11564977 [TBL] [Abstract][Full Text] [Related]